Amsel Medical Corporation
1 known investors
Amsel Medical develops the SCureClamp with iDOT (Interdigitation Occlusion Technology), a mechanical surgical clamp delivered through an 18 G needle to occlude veins, arteries, ducts, and other tubular structures during surgical and interventional procedures. The FDA-cleared and CE-marked device targets vascular disease, general surgery, and military trauma applications and is used by vein, vascular, cardiovascular, and general surgeons, interventional radiologists, and military medical personnel.
Investors · 1
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase II | 2022 | $1.5M |
| U.S. Air ForceAir Force | Phase II | 2020 | $1000K |
| U.S. Air ForceAir Force | Phase I | 2019 | $49.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Amsel Medical Corporation do?
- Amsel Medical develops the SCureClamp with iDOT (Interdigitation Occlusion Technology), a mechanical surgical clamp delivered through an 18 G needle to occlude veins, arteries, ducts, and other tubular structures during surgical and interventional procedures. The FDA-cleared and CE-marked device targets vascular disease, general surgery, and military trauma applications and is used by vein, vascular, cardiovascular, and general surgeons, interventional radiologists, and military medical personnel.
- Who are Amsel Medical Corporation's investors?
- Amsel Medical Corporation's investors include Boston Harbor Angels.